Xiamen, China

Ji Miao



Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2014-2017

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Ji Miao

Introduction

Ji Miao is a prominent inventor based in Xiamen, China. He has made significant contributions to the field of biotechnology, particularly in the development of vaccines and treatments for viral infections. With a total of three patents to his name, Ji Miao's work has the potential to impact public health positively.

Latest Patents

One of Ji Miao's latest patents is related to a truncated L1 protein of human papillomavirus type 6. This invention involves a virus-like particle consisting of the truncated L1 protein, a vaccine that incorporates this particle, and its application in preventing condyloma acuminatum or HPV infections. Another notable patent focuses on RNA interference targets for treating AIDS. This patent outlines RNAi target sequences that can be utilized to treat AIDS by targeting HIV. Ji Miao has developed recombinant expression vectors, packaging vectors, and cells that express siRNA, miRNA, ribozyme, or antisense oligonucleotide for targeting HIV, which can be used in preparing medicaments for treating AIDS.

Career Highlights

Ji Miao has worked at Xiamen University and Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of Ji Miao's notable coworkers include Jun Zhang and Ningshao Xia. Their collaborative efforts have further advanced the research and development of innovative solutions in biotechnology.

Conclusion

Ji Miao's contributions to the field of biotechnology through his patents and collaborations highlight his role as an influential inventor. His work in developing vaccines and treatments for viral infections showcases the importance of innovation in addressing public health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…